首页 › 基金 › 683 Capital Management, LLC › PHAT

683 Capital Management, LLC 对 PHAT 的持仓历史

PHATHOM PHARMACEUTICALS INC · 医疗保健

683 Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 PHAT(PHATHOM PHARMACEUTICALS INC)2,000,000 股,市值约 US$14.6M,约占其申报组合的 0.65%,在其申报持仓中市值排名第 32 位。 683 Capital Management, LLC 最近 13 个申报季度中有 13 个季度披露了 PHAT 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)2.00M 股
申报持仓市值$14.60M
组合权重0.65%
首次申报Q3 2023
最近变动增持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

683 Capital Management, LLC 对 PHAT 的持仓演变

683 Capital Management, LLC 于 Q3 2023 首次披露 PHAT 持仓:1,100,000 股(约 US$11.4M)。 该持仓在 Q4 2025 达到峰值 1,785,000 股,市值约 US$29.6M。 在 13 次申报中,683 Capital Management, LLC 7 次增持、4 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 2,000,000 股、市值约 US$14.6M,环比增持 150,000 股。。 持仓曾出现大幅变动:Q1 2024 增持约 29% (随后一个季度股价下跌 3%)、Q1 2025 增持约 41% (随后一个季度股价上涨 53%)、Q2 2025 增持约 46% (随后一个季度股价上涨 23%)。

逐季持仓明细

季度股数金额变化
Q3 2023 1.10M $11.41M 新进
Q4 2023 1.28M $11.69M 增持
Q1 2024 1.65M $17.52M 增持
Q2 2024 1.40M $14.42M 减持
Q3 2024 1.01M $18.26M 减持
Q4 2024 1.02M $8.32M 增持
Q1 2025 1.45M $9.06M 增持
Q2 2025 2.10M $20.19M 增持
Q3 2025 1.82M $21.43M 减持
Q4 2025 1.78M $29.61M 减持
Q1 2026 1.85M $20.55M 增持
Q2 2026 1.85M $20.07M 持有
Q3 2026 2.00M $14.60M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 PHAT 与 13F 数据

PHAT(PHATHOM PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 24 只申报持有 PHAT,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$135.3M), Medicxi Ventures Management (Jersey) Ltd (US$54.5M), Carlyle Group Inc. (US$25.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PHAT 的基金

查看 PHAT 的全部基金持有人 →

常见问题

How long has 683 Capital Management, LLC held PHAT?

683 Capital Management, LLC has disclosed PHAT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is 683 Capital Management, LLC's current position in PHAT?

As of Q3 2026, 683 Capital Management, LLC holds 2.00M shares of PHAT (PHATHOM PHARMACEUTICALS INC), valued at $14.60M, representing 0.65% of its reported portfolio and ranking #32.

Has 683 Capital Management, LLC been buying or selling PHAT?

In the latest 13F filing (Q3 2026), 683 Capital Management, LLC increased its position in PHAT. The position peaked in Q4 2025 at 1.78M shares.

Which other funds hold PHAT?

Other major institutional holders of PHAT include Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Carlyle Group Inc., among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.